OF SKIN OF THE HEAD AND NECK (ICD‐O‐3 C44.0, C44.2–4)



CARCINOMA OF SKIN OF THE HEAD AND NECK (ICD‐O‐3 C44.0, C44.2–4)


Rules for Classification


The classification applies only to carcinomas, excluding Merkel cell carcinoma. There should be histological confirmation of the disease and division of cases by histological type.


Anatomical Sites and Subsites


The following sites are identified by ICD‐O‐3 topography rubrics (see Fig. 334):



  • Lip (excluding vermilion surface) (C44.0)
  • External ear (C44.2)
  • Other and unspecified parts of face (C44.3)
  • Scalp and neck (C44.4)
Schematic illustration of ICD-O topography rubrics, Lip, External ear, Other and unspecified parts of face, Scalp and neck.

Fig. 334


Regional Lymph Nodes


The regional lymph nodes are Ipsilateral preauricular, submandibular, cervical and supraclavicular lymph nodes (see Fig. 335).

Schematic illustration of The regional lymph nodes are Ipsilateral preauricular, submandibular, cervical and supraclavicular lymph nodes.

Fig. 335


TNM Clinical Classification


T – Primary Tumour



























Tx Primary tumour cannot be assessed
T0 No evidence of primary tumour
Tis Carcinoma in situ (Fig. 336)
T1 Tumour 2 cm or less in greatest dimension (Fig. 337)
T2 Tumour > 2 cm and ≤ 4 cm in greatest dimension (Fig. 338)
T3 Tumour > 4 cm in maximum dimension or minor bone erosion or perineural invasion or deep invasion* (Fig. 339)
T4a Tumour with gross cortical bone/marrow invasion
T4b Tumour with skull base or axial skeleton invasion including foraminal involvement and/or vertebral foramen involvement to the epidural space

Note
*In the case of multiple simultaneous tumours, the tumour with the highest T category is classified and the number of separate tumours is indicated in parentheses, e.g., T2(5) (Fig. 340)

Schematic illustration of Carcinoma in situ, Epithelium, Papillary dermis, Reticular dermis, Subcutaneous tissue.

Fig. 336

Schematic illustration of Tumor 2 cm or less in greatest dimension.

Fig. 337

Schematic illustration of Tumor greater than or equal to 2 cm and less than or equal to 4 cm in greatest dimension.

Fig. 338

Schematic illustration of Tumor greater than or equal to 4 cm in maximum dimension or minor bone erosion or perineural invasion or deep invasion.

Fig. 339

Schematic illustration of the tumour with the highest T category is classified and the number of separate tumours is indicated in parentheses.

Fig. 340


N – Regional Lymph Nodes



























N0 No regional lymph node metastasis
N1 Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension without extranodal extension (Fig. 341)
N2 Metastasis as described below:
N2a Metastasis in a single ipsilateral lymph node more than 3 cm but not more than 6 cm in greatest dimension without extranodal extension (Fig. 342)
N2b Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, without extranodal extension (Fig. 343)
N2c Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension, without extranodal extension (Fig. 344)
N3a Metastasis in a lymph node more than 6 cm in greatest dimension without extranodal extension (Fig. 345)
N3b Metastasis in single or multiple lymph nodes with clinical extranodal extension

Note
*The presence of skin involvement or soft tissue invasion with deep fixation/tethering to underlying muscle or adjacent structures or clinical signs of nerve involvement is classified as clinical extranodal extension.

Schematic illustration of Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension without extranodal extension.

Fig. 341

Schematic illustration of Metastasis in a single ipsilateral lymph node more than 3 cm but not more than 6 cm in greatest dimension without extranodal extension.

Fig. 342

Schematic illustration of Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, without extranodal extension.

Fig. 343

Schematic illustration of Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension, without extranodal extension.

Fig. 344

Schematic illustration of Metastasis in a lymph node more than 6 cm in greatest dimension without extranodal extension.

Fig. 345


M – Distant Metastasis









M0 No distant metastasis
M1 Distant metastasis

pTNM Pathological Classification


The pT categories correspond to the T categories


pN – Regional Lymph Nodes


Histological examination of a selective neck dissection specimen will ordinarily include 10 or more lymph nodes. Histological examination of a radical or modified radical neck dissection specimen will ordinarily include 15 or more lymph nodes.






























pNX Regional lymph nodes cannot be assessed
pN0 No regional lymph node metastasis
pN1 Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension without extranodal extension
pN2 Metastasis as described below:
pN2a Metastasis in a single ipsilateral lymph node, less than 3 cm in greatest dimension with extranodal extension, or more than 3 cm but not more than 6 cm in greatest dimension without extranodal extension
pN2b Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension without extranodal extension
pN2c Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension without extranodal extension
pN3a Metastasis in a lymph node more than 6 cm in greatest dimension without extranodal extension
pN3b Metastasis in a lymph node more than 3 cm in greatest dimension with extranodal extension, or multiple ipsilateral, contralateral or bilateral, with extranodal extension

pM – Distant metastasis






pM1 Distant metastasis microscopically confirmed

Note
pM0 and pMx are not categories


Summary

Tags:
Dec 15, 2022 | Posted by in ONCOLOGY | Comments Off on OF SKIN OF THE HEAD AND NECK (ICD‐O‐3 C44.0, C44.2–4)

Full access? Get Clinical Tree

Get Clinical Tree app for offline access